Testicular Sperm Extraction (TESE) Procedure
For men with non-obstructive azoospermia requiring surgical sperm retrieval, microdissection TESE (micro-TESE) is the preferred technique over conventional TESE, offering 1.5 times higher sperm retrieval rates with fewer complications. 1
What is TESE?
TESE is a surgical procedure to retrieve sperm directly from testicular tissue for use in assisted reproductive technology (specifically ICSI - intracytoplasmic sperm injection). Two main techniques exist:
Conventional TESE (cTESE)
- Involves random biopsies of testicular tissue
- Sperm retrieval rate: approximately 50% 2
- Higher complication rates (hematoma, fibrosis) 2
- Greater negative impact on postoperative testosterone levels 1
Microdissection TESE (micro-TESE)
- Uses operative microscopy to identify seminiferous tubules most likely to contain sperm
- Wide opening of tunica albuginea allows examination of multiple testicular regions
- Tissue oriented in centrifugal pattern parallel to intratesticular blood supply
- Minimizes inadvertent vascular damage 1
- Sperm retrieval rate: 1.5 times higher than conventional TESE 1
- Lower complication rates for hematoma and fibrosis 2
- Less impact on testosterone levels (though testosterone deficiency requiring replacement remains a risk) 1
Primary Indications
Non-Obstructive Azoospermia (NOA)
- Primary indication for TESE 3
- Includes: Klinefelter syndrome, post-chemotherapy, idiopathic NOA, AZFc microdeletions
- Micro-TESE particularly advantageous when testicular volume <12 mL 3
Obstructive Azoospermia (OA)
- TESE is an option when microsurgical reconstruction (vasovasostomy/epididymovasostomy) is not feasible or has failed 4
- Important caveat: Epididymal sperm retrieval should be avoided if future microsurgical reconstruction might be pursued due to risk of epididymal scarring 1
- Fertilization, pregnancy, and live birth rates are similar for epididymal vs. testicular sperm in obstructive cases 1
Emerging Indications (Non-Azoospermic Men)
- Elevated sperm DNA Fragmentation Index (DFI): Testicular sperm shows improved clinical pregnancy rates, live births, and reduced pregnancy loss compared to ejaculated sperm 1
- Cryptozoospermia
- Necrospermia
- Recurrent IVF failure with ejaculated sperm 5
Fertility Preservation
- Pre-gonadotoxic therapy: Sperm banking preferred, but TESE option if azoospermic 1
- Post-gonadotoxic therapy: Micro-TESE for persistent azoospermia (Strong Recommendation, Grade B) 1
- Testicular cancer (onco-TESE): Simultaneous radical orchiectomy and micro-TESE for azoospermic patients 6, 7, 8
Contraindications
Complete AZFa and AZFb microdeletions: Sperm retrieval likelihood is almost zero; TESE is contraindicated 2
Predictive Factors for Success
Favorable Factors
- Hypospermatogenesis pattern on testicular biopsy: Best predictor of successful sperm retrieval 2
- AZFc microdeletions (not AZFa/AZFb) 3
Unfavorable Factors
Inconsistent/Limited Predictive Value
- FSH, LH, inhibin B, AMH levels: Variable correlation, limited retrospective data 2
- Testicular volume: Inconsistent predictor 2
Pre-Operative Evaluation
Essential workup before TESE:
- Hormone status (FSH, LH, testosterone)
- Genetic testing: Karyotype and Y-chromosome microdeletion analysis
- Counsel on costs and possibility of unsuccessful sperm retrieval 3
- Do NOT perform testicular FNA mapping: No RCTs support its use; requires two procedures instead of one, delays treatment 2
Surgical Technique (Micro-TESE)
- Wide opening of tunica albuginea
- Systematic examination of multiple testicular regions under operative microscopy
- Identification of larger, more opaque seminiferous tubules (higher likelihood of spermatogenesis)
- Selective excision of promising tubules
- Tissue oriented parallel to intratesticular blood supply to minimize devascularization 1
Key technical point: Multiple biopsies increase sperm retrieval success 2
Post-Operative Care and Monitoring
Immediate Complications (Rare)
- Bleeding/hematoma
- Infection
- Testicular atrophy 3
Long-Term Monitoring
Critical: Monitor for post-operative hypogonadism
- Both conventional TESE and micro-TESE can cause testosterone decline
- Micro-TESE has less impact than conventional TESE 1
- Many NOA patients have baseline testosterone deficiency 1
- Testosterone replacement may be required post-operatively 1
- Recovery of baseline testosterone at long-term follow-up observed in many cases 2
Alternative Options
Medical Optimization (Limited Evidence)
For NOA patients, may consider off-label pharmacologic manipulation before surgery:
- Selective estrogen receptor modulators (SERMs)
- Aromatase inhibitors (AIs)
- Gonadotropins (hCG)
- Caveat: Only subset of patients eligible based on hormonal profile; limited outcome data 1
Salvage Micro-TESE
- 46.5% success rate in patients with prior failed conventional TESE or testicular sperm aspiration 2
- Demonstrates superiority of micro-TESE technique
Donor Sperm
- Alternative if TESE unsuccessful or contraindicated
Collaboration Requirements
Essential multidisciplinary approach:
- Urologist/andrologist
- Reproductive endocrinologist
- Embryologist
- Human geneticist 3
Evidence Quality Note
The 2025 EAU guidelines acknowledge that current evidence is low quality with paucity of RCTs comparing conventional TESE and micro-TESE 2. Despite meta-analyses showing comparable sperm retrieval rates, all individual trials showed micro-TESE superiority, and complications are consistently lower with micro-TESE. The consensus expert opinion strongly favors micro-TESE as the optimum approach 2.